News Releases

Concord Medical Services Celebrates IPO, First Day of NYSE Trading
Beijing / New York, December 11, 2009 – Executives and guests of Concord Medical Services Holdings Limited (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, visited the NYSE today in celebration of the company’s successful initial public offering, in which it raised $132 million.

“We are pleased with the success of our initial public offering and the beginning of our partnership with the NYSE,” said Dr. Yang Jianyu, CEO and President of CMS.   “We believe that through this IPO, CMS can connect the medical services industry in China with the international capital markets, and provide international investors the opportunity to participate in the growth of the Chinese healthcare sector.” 

“Through its NYSE listing, Concord Medical has the opportunity to establish a strong footprint in the U.S. , access the world’s largest pool of investors, and grow its presence in the international capital markets,” said Michael Yang, Chief Representative and Head of China office, NYSE Euronext. “We look forward to strong and lasting partnerships with CMS and its shareholders.”

NYSE Euronext currently lists 79 companies from Greater China with a combined total global market capitalization of approximately $1.1 trillion (as of 12/11/09), including 18 companies from China on NYSE Amex.

Please click here for a photo of the company visiting the NYSE:

NYSE Euronext lists more issues than any other exchange
NYSE Euronext markets list 8,000 issues with a total combined market capitalization of $21.4 trillion (as of Nov. 30, 2009), more than any other exchange group in the world.

About Concord Medical Services Holdings Limited
CMS operates China 's largest network of radiotherapy and diagnostic imaging centers in terms of revenue and total number of centers in operation in 2008.  Since the establishment, CMS has been committed to building an extensive network of radiotherapy and diagnostic imaging centers in China , employing state-of-the art medical technology to sustain lives and reduce suffering. Today, the Company operates a network of more than 80 centers spanning more than 35 cities and 20 provinces and administrative regions in China .  Learn more at

About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies.  The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products.  With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, NYSE Euronext, NYSE Amex and NYSE Alternext as well as NYSE Arca – represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group.  NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies.  NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100  index and Fortune 500.  For more information, please visit:

Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2008 (“document de référence”) filed with the French Autorité des Marchés Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

Contact Information
Integrated Corporate Relations, Inc.
In New York : Ashley M. Ammon: 1-646-277-1227
In Beijing : Michael Tieu: 86-10-6599-7968
Email to:


Contact: Christiaan Brakman
Phone: 212.656.2094